Skip to main content

Stephen Mora

Institutions of which they are part

Neurodegenerative Diseases
Vall Hebron Institut de Recerca
Stephen  Mora

Stephen Mora

Stephen  Mora

Institutions of which they are part

Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Related news

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

This initiative is part of a pioneering study that seeks to assess how the relationship between different age groups can influence the quality of life and mental health of patients.

Related professionals

Rosa Burgos Peláez

Rosa Burgos Peláez

Main researcher
Read more
Pol Ibañez Jimenez

Pol Ibañez Jimenez

Research assistant
Psychiatry, Mental Health and Addictions
Read more
Consuelo Pedrós Cholvi

Consuelo Pedrós Cholvi

Clinical Pharmacology
Read more
Cristina Vetoret Vázquez

Cristina Vetoret Vázquez

Research assistant
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.